{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:24:50Z","timestamp":1789809890732,"version":"4.0.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0078582","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T17:15:06Z","timestamp":1383671706000},"page":"e78582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib"],"prefix":"10.1371","volume":"8","author":[{"given":"Vanessa","family":"Augis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Airiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Josselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Turcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Belloc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"M Baccarani","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/cncr.20922","article-title":"Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up","volume":"103","author":"T Lahaye","year":"2005","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Baran Y, Ural AU, Gunduz U (2007) Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Hematology: 1.","DOI":"10.1080\/10245330701384179"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","article-title":"The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells","volume":"90","author":"MW Deininger","year":"1997","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/MCB.21.3.854-864.2001","article-title":"Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors","volume":"21","author":"T Shinjyo","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","article-title":"Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors","volume":"24","author":"R Kuribara","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/cbt.6.6.4101","article-title":"Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines","volume":"6","author":"F Belloc","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"KP Ng","year":"2012","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"T Hughes","year":"2006","journal-title":"Blood"},{"key":"ref10","first-page":"93","article-title":"Detection of BCR-ABL mutations and resistance to imatinib mesylate","volume":"125","author":"S Branford","year":"2006","journal-title":"Methods Mol Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","article-title":"Bim: a novel member of the Bcl-2 family that promotes apoptosis","volume":"17","author":"L O'Connor","year":"1998","journal-title":"EMBO J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"FX Mahon","year":"2000","journal-title":"Blood"},{"key":"ref13","unstructured":"SNPstats software. Available : <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/bioinfo.iconcologia.net\/snpstats\/start.htm\" xlink:type=\"simple\">http:\/\/bioinfo.iconcologia.net\/snpstats\/start.htm<\/ext-link>. Accessed 2012."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"X Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"ref15","unstructured":"International HapMap project website. Available <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/hapmap.ncbi.nlm.nih.gov\/\" xlink:type=\"simple\">http:\/\/hapmap.ncbi.nlm.nih.gov\/<\/ext-link> Accessed 2008"},{"key":"ref16","unstructured":"dbSNP website. Available <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/SNP\/\" xlink:type=\"simple\">http:\/\/www.ncbi.nlm.nih.gov\/SNP\/<\/ext-link>. Accessed 2008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia","volume":"101","author":"A Egle","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas","volume":"109","author":"C Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A &quot;silent&quot; polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"C Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor","volume":"12","author":"J Duan","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1158\/0008-5472.CAN-07-2377","article-title":"Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer","volume":"67","author":"ZE Sauna","year":"2007","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2008-03-147744","article-title":"Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"112","author":"S Dulucq","year":"2008","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12263-007-0052-3","article-title":"Evidence that a polymorphism within the 3&apos;UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer","volume":"2","author":"G Bermano","year":"2007","journal-title":"Genes Nutr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"C Xiao","year":"2008","journal-title":"Nat Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1158\/1055-9965.EPI-10-0581","article-title":"Germline variation in apoptosis pathway genes and risk of non-Hodgkin&apos;s lymphoma","volume":"19","author":"JL Kelly","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref26","unstructured":"SNP@promoter website. Available : <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/variome.kobic.re.kr\/SNPatPromoter\" xlink:type=\"simple\">http:\/\/variome.kobic.re.kr\/SNPatPromoter<\/ext-link>. Accessed 2008."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(01)03145-3","article-title":"Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family","volume":"509","author":"M U","year":"2001","journal-title":"FEBS Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10495-007-0093-5","article-title":"Identification and characterization of BH3 domain protein Bim and its isoforms in human hepatocellular carcinomas","volume":"12","author":"J Miao","year":"2007","journal-title":"Apoptosis"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Airiau K, Mahon FX, Josselin M, Jeanneteau M, Turcq B, <etal>et al<\/etal>.. (2012) ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib. Exp Hematol 40: 367\u2013378 e362.","DOI":"10.1016\/j.exphem.2012.01.004"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0078582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T07:02:51Z","timestamp":1596783771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0078582"}},"subtitle":[],"editor":[{"given":"Ivan Cruz","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,5]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0078582","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,5]]}}}